Literature DB >> 6860148

Replication of virulent and attenuated strains of yellow fever virus in human monocytes and macrophage-like cells (U937).

F Liprandi, R Walder.   

Abstract

Virulent and attenuated strains of yellow fever virus were compared for their ability to grow in cultures of unstimulated leucocytes and monocytes derived from human peripheral blood, and of a macrophage-like cell line of human origin, U937. The extent of virus growth in leucocyte cultures varied depending on the strain of virus, multiplicity of infection, presence of diluted antibody in the culture medium but independently of the flavivirus immune status of the donor. The same pattern of differential growth was observed in the three types of cultures used. Although strain related variation in growth occurred within both virulent and attenuated strains, most of the attenuated strains produced higher virus yields than the virulent ones, suggesting that replication in this cell system is not related to the expression of virulence for the host. Replication in human monocytes as an in vitro marker of immunogenity for substrains of 17 D vaccine virus is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6860148     DOI: 10.1007/bf01315703

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  23 in total

1.  Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes.

Authors:  W E Brandt; J M McCown; F H Top; W H Bancroft; P K Russell
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

2.  Abortive and productive infections of human mononuclear phagocytes by type I herpes simplex virus.

Authors:  C A Daniels; E S Kleinerman; R Snyderman
Journal:  Am J Pathol       Date:  1978-04       Impact factor: 4.307

Review 3.  Role of macrophages in natural resistance to virus infections.

Authors:  S C Mogensen
Journal:  Microbiol Rev       Date:  1979-03

4.  Specific role of each human leukocyte type in viral infections. 3. 17D yellow fever virus replication and interferon production in homogeneous leukocyte cultures treated with phytohemagglutinin.

Authors:  E F Wheelock; R Edelman
Journal:  J Immunol       Date:  1969-09       Impact factor: 5.422

5.  Permissiveness of rabbit monocytes and macrophages for herpes simplex virus type 1.

Authors:  S Plaeger-Marshall; L A Wilson; J W Smith
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

Review 6.  Review article initial stages in infection with animal viruses.

Authors:  N J Dimmock
Journal:  J Gen Virol       Date:  1982-03       Impact factor: 3.891

7.  Antibody-mediated infection of macrophages and macrophage-like cell lines with 17D-yellow fever virus.

Authors:  J J Schlesinger; M W Brandriss
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

8.  Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues.

Authors:  T P Monath; K R Brinker; F W Chandler; G E Kemp; C B Cropp
Journal:  Am J Trop Med Hyg       Date:  1981-03       Impact factor: 2.345

9.  WHO Expert Committee on Yellow Fever. Third report.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1971

10.  Isolation of plaque variants differing in virulence from the 17D strain of yellow fever virus.

Authors:  F Liprandi
Journal:  J Gen Virol       Date:  1981-10       Impact factor: 3.891

View more
  7 in total

Review 1.  Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.

Authors:  Huabin Liang; Min Lee; Xia Jin
Journal:  Cell Mol Immunol       Date:  2015-10-05       Impact factor: 11.530

2.  Replication of alphaviruses in cultures of donkey monocytes.

Authors:  F Liprandi; B Gómez; R Walder
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

3.  Present status of yellow fever: memorandum from a PAHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

Review 4.  What Does the Future Hold for Yellow Fever Virus? (II).

Authors:  Raphaëlle Klitting; Carlo Fischer; Jan F Drexler; Ernest A Gould; David Roiz; Christophe Paupy; Xavier de Lamballerie
Journal:  Genes (Basel)       Date:  2018-08-21       Impact factor: 4.096

5.  Human Schwann cells are susceptible to infection with Zika and yellow fever viruses, but not dengue virus.

Authors:  Gaurav Dhiman; Rachy Abraham; Diane E Griffin
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

6.  A mouse model for studying viscerotropic disease caused by yellow fever virus infection.

Authors:  Kathryn C Meier; Christina L Gardner; Mikhail V Khoretonenko; William B Klimstra; Kate D Ryman
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

7.  Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury.

Authors:  Adam L Bailey; Liang-I Kang; Luiz Gonzaga Francisco de Assis Barros D'Elia Zanella; Cássia G T Silveira; Yeh-Li Ho; Lander Foquet; Greg Bial; Broc T McCune; Amaro Nunes Duarte-Neto; Archana Thomas; Hans-Peter Raué; Kathleen Byrnes; Esper G Kallas; Mark K Slifka; Michael S Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-02       Impact factor: 12.779

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.